Sarker Malabika, Jatoi Ismail, Becher Heiko
Department of Tropical Hygiene and Public Health, University of Heidelberg, INF 324, 69120, Heidelberg, Germany.
Breast Cancer Res Treat. 2007 Nov;106(1):135-41. doi: 10.1007/s10549-006-9478-3. Epub 2007 Feb 13.
There is a known difference in breast cancer survival between races in the US for which several factors such as social, lifestyle and genetic factors may be relevant.
This is a retrospective study among women entitled to free treatment in the US department of defense health care system. Within this group, we investigated the temporal trend of absolute survival of 13,793 of White and African American aged 20-59 years and diagnosed between 1980 and 1999 with breast cancer.
There is a 3% overall improvement in survival in whites which can be explained by an earlier detection, and a two percent decrease in AA with a distinct pattern by age group. In the 40-49 year age group, the survival in white increases from 84.5% in the year 1980-1984 to 87.4 % in the year 1995-1999, in AA we estimate a decrease from 79.7% to 78.5%. When accounting for stage at diagnosis a slight reduction in survival in whites and a strong reduction in AA indicates a significant interaction between race and calendar period. The differences in survival patterns between blacks and whites are mainly caused by breast cancer and not by other causes.
The gap in survival which strongly increased with calendar period cannot be explained by unequal access to health care. Possible explanations include a lower participation of early detection programs for breast cancer in AA and an increasing prevalence of obesity over time which is more pronounced in AA than in whites.
在美国,不同种族之间乳腺癌生存率存在已知差异,社会、生活方式和遗传等多种因素可能与之相关。
这是一项针对美国国防部医疗保健系统中有权享受免费治疗的女性的回顾性研究。在该群体中,我们调查了1980年至1999年间确诊的13793名年龄在20至59岁之间的白人和非裔美国女性乳腺癌患者的绝对生存时间趋势。
白人患者的总体生存率提高了3%,这可以通过早期检测来解释;非裔美国患者的生存率下降了2%,且各年龄组呈现出不同模式。在40至49岁年龄组中,白人患者的生存率从1980年至1984年的84.5%增至1995年至1999年的87.4%,而非裔美国患者的生存率则从79.7%降至78.5%。考虑到诊断时的分期,白人患者生存率略有下降,非裔美国患者生存率大幅下降,这表明种族与时间周期之间存在显著交互作用。黑人和白人患者生存模式的差异主要由乳腺癌导致,而非其他原因。
生存率差距随时间周期大幅增加,无法用获得医疗保健机会不平等来解释。可能的解释包括非裔美国女性参与乳腺癌早期检测项目的比例较低,以及肥胖患病率随时间增加,且非裔美国女性的肥胖情况比白人女性更为明显。